perampanel: Clinical Trials

18 trials of perampanel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 5 terminated. 18 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 13, Terminated 5
Phase 22Completed 2

Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perampanel in Focal Status Epilepticus
Perampanel, Placebo - Epilepticus; Status, Focal Motor
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris12022-11-022023-12-14
Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)
E2007 - Partial Onset Seizures
Phase 3CompletedEisai Co., Ltd.912017-06-282021-08-05
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Placebo, Perampanel - Lennox-Gastaut Syndrome (LGS)
Phase 3TerminatedEisai Inc.1012016-12-132022-03-09
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Perampanel - Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Phase 3CompletedEisai Inc.1802016-11-162022-10-28
An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
Perampanel - Epilepsy
Phase 3CompletedEisai Co., Ltd.72015-05-122018-07-02
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
Perampanel, Placebo - Partial-onset Seizures
Phase 3CompletedEisai Co., Ltd.9402012-05-152021-07-29
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
Perampanel, Placebo comparator - Seizure Disorder Generalized Tonic Clonic
Phase 3CompletedEisai Inc.1632011-09-012017-08-28
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
perampanel - Epilepsy
Phase 3CompletedEisai Inc.12182008-10-012016-03-14
Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
perampanel, Placebo - Refractory Partial Seizures
Phase 3CompletedEisai Inc.7122008-08-012016-01-21
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
E2007 (perampanel), Placebo - Refractory Partial Seizures
Phase 3CompletedEisai Inc.3892008-05-012014-07-11
Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
E2007 (perampanel), Placebo - Refractory Partial Seizures
Phase 3CompletedEisai Inc.3902008-04-302020-01-10
Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
E2007 - Neuralgia
Phase 2 / Phase 3CompletedEisai Inc.2622008-01-012016-01-21
Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations
Perampanel - Parkinson's Disease
Phase 3TerminatedEisai Limited3282007-07-012016-01-21
An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy
Placebo, E2007 (2 mg), E2007 (4 mg) - Diabetic Neuropathy
Phase 2 / Phase 3CompletedEisai Inc.3522007-06-012014-07-11
Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Placebo, E2007 - Parkinson's Disease
Phase 3TerminatedEisai Limited7232006-11-012014-07-11
A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
E2007 - Parkinson's Disease
Phase 3TerminatedEisai Inc.9972006-10-012014-07-11
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
2 mg perampanel, 4 mg perampanel, placebo comparator - Parkinson's Disease
Phase 3CompletedEisai Inc.7522006-08-012013-05-20
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
E2007 - Parkinson's Disease
Phase 3CompletedEisai Limited7022006-02-012015-11-03

Conditions studied

Parkinson Disease (5)  ·  Epilepsy (4)  ·  Seizures (4)  ·  Diabetic Neuropathies (1)  ·  Lennox Gastaut Syndrome (1)  ·  Neuralgia (1)

Sponsors

Eisai Inc. (11)  ·  Eisai Co., Ltd. (3)  ·  Eisai Limited (3)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (8)  ·  France (7)  ·  South Korea (6)  ·  Belgium (5)  ·  Czechia (5)  ·  Germany (5)  ·  Italy (5)  ·  Japan (5)  ·  Australia (4)  ·  Canada (4)  ·  Hungary (4)  ·  India (4)  ·  Poland (4)  ·  Spain (4)  ·  Austria (3)

Top investigators

David Squillacote, M.D. (6)  ·  Alessia Nicotra, MD, PhD, DIC (1)  ·  Antonio Laurenza, M. D. (1)  ·  Antonio Laurenza, M.D. (1)  ·  David Squillacote, MD (1)  ·  Francesco Bibbiani (1)  ·  Michelle Gee, PhD. (1)  ·  Vincent Navarro, DDS,PhD (1)

Results publications

PMID 25823975, PMID 35305920, PMID 37059702, PMID 23663001, PMID 25878175, PMID 22517103, PMID 22843280, PMID 22905857, PMID 24867391, PMID 26296511, PMID 29250772, PMID 29574701, PMID 31912493, PMID 33825230, PMID 33839450, PMID 34657389, PMID 36106379

NIH funding

2014 (2), 2005 (1), 2019 (1)